Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2024-08-09 00:00:00 ET · period of report 2024-08-09 · accession 0000950170-24-094967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-08-09 | 2024-08-09 | AXSM | Jacobson Mark L. | COO | M - OptEx | $4.04 | +47.7K | 53.5K | +826% | +$192.9K |
| DT | 2024-08-09 | 2024-08-09 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $84.26 | -47.7K | 5,783 | -89% | -$4.02M |
| DT | 2024-08-09 | 2024-08-09 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -47.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-09 | M | A | 47,739 | $4.04 | 53,522 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-09 | S | D | 47,739 | $84.26 | 5,783 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $82.705 and $85.975. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-09 | M | D | 47,739 | $0.00 | 0 | D | $4.04 · 2015-12-29 to 2024-12-29 | 47,739 Common Stock |